Page 3 - Vbi Vaccines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vbi vaccines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vbi Vaccines Today - Breaking & Trending Today

VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences

CAMBRIDGE, Mass., February 14, 2024 VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI" or the "Company"), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced agreements whereby Brii Biosciences ("Brii Bio"), subject to certain activities, is expected to: (i) acquire the intellectual property for VBI-2601, VBI’s HBV immunotherapeutic development program, and eliminate payment obligations from the July 2023 agreements between VBI a ....

United States , United Kingdom , Nicole Anderson , Prehevbrio Prehevbri , Asia Pacific , Brii Bio , Brii Biosciences Bio , Jeff Baxter , Corporate Communications , Vaccines Inc , Company Quarterly Reports On Form , Brii Biosciences , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Vbi Vaccines , The Company , Brii Biosciences , Brii Bio , Iopharmaceutical Company ,

VBI Vaccines (NASDAQ:VBIV) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research note issued on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Performance Shares of NASDAQ:VBIV opened at $0.61 on Friday. The company has a market capitalization of $14.45 million, a […] ....

Frontier Wealth Management , Vaccines Inc , Renaissance Technologies , Millennium Management , Get Free Report , Street Corp , Financial Advisors , Wealth Management , Vbi Vaccines , Nasdaq Vbiv , Initiated Coverage , Stocknews Com ,

Seres Therapeutics (NASDAQ:MCRB) & VBI Vaccines (NASDAQ:VBIV) Head to Head Comparison

VBI Vaccines (NASDAQ:VBIV – Get Free Report) and Seres Therapeutics (NASDAQ:MCRB – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, analyst recommendations and institutional ownership. Profitability This table compares VBI Vaccines and […] ....

United States , United Kingdom , Produits Nestl , Seres Health Inc , Scivac Therapeutics Inc , Coalition For Epidemic Preparedness Innovations , Seres Therapeutics Inc , National Research Council Of Canada , Vaccines Inc , Brii Biosciences , Astrazeneca Inc , Get Free Report , Seres Therapeutics , Seres Therapeutic , Given Seres Therapeutic , Brii Biosciences Limited , National Research Council , Middle East , Epidemic Preparedness Innovations , Scivac Therapeutics , Des Produits Nestl , Seres Health , Vbi Vaccines , Nasdaq Vbiv , Stock Comparison , Stock Analysis ,

VBI Vaccines Inc. (NASDAQ:VBIV) Short Interest Down 42.1% in November

VBI Vaccines Inc. (NASDAQ:VBIV – Get Free Report) saw a significant decline in short interest in November. As of November 30th, there was short interest totalling 268,100 shares, a decline of 42.1% from the November 15th total of 463,000 shares. Currently, 1.2% of the company’s stock are sold short. Based on an average daily volume […] ....

Frontier Wealth Management , Vaccines Company Profile , Vbi Vaccines Inc , Renaissance Technologies , Vaccines Inc , Millennium Management , Get Free Report , Trading Down , Street Corp , Financial Advisors , Wealth Management , Vbi Vaccines , Nasdaq Vbiv ,

VBI Vaccines (NASDAQ:VBIV) Share Price Crosses Below Two Hundred Day Moving Average of $2.77

VBI Vaccines Inc. (NASDAQ:VBIV – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.77 and traded as low as $0.72. VBI Vaccines shares last traded at $0.73, with a volume of 728,286 shares traded. Wall […] ....

Steven Gillis , Vaccines Inc , Securities Exchange Commission , Millennium Management , Vbi Vaccines Inc , Goldman Sachs Group Inc , Charles Schwab Investment Management Inc , Get Free Report , Director Steven Gillis , Exchange Commission , Street Corp , Schwab Investment Management , Sachs Group , Vbi Vaccines , Nasdaq Vbiv ,